WHO
-
A Milliliter of Cure: How Investment in Vaccine Provision Could Yield Substantial Economic Returns
•
A new study finds that investments aimed at increasing vaccine coverage reap significant economic benefits in the long run, particularly in developing countries.
-
Antibiotic Breach: The Fall of Another Powerful Antibiotic Drug
•
This study presents the first observed case of transmittable antibiotic resistance to colistin, one of the most potent antibiotics available. Colistin belongs to a class of antibiotics of “last resort,” called polymyxin. The study highlights the need for increased regulation of antimicrobial use to avoid a global health crisis.
-
Up to Date on the Ebola Crisis
•
The recent Ebola epidemic, which started in Guinea in early 2014 and soon spread throughout Western Africa, has resulted in 10 cases treated on American soil – with two deaths. The US government has since worked to prevent the spread of the epidemic both at home and abroad by: Instituting controversial 21-day monitoring and…
-
Ebola’s Devastation: On the Ground in Liberia
•
Aid worker Nina Goricar gives an eye-witness account of the Ebola quarantine in Monrovia, what’s missing from mainstream media coverage, and the effect of the crisis on Liberia’s basic health care and civic institutions.